Switzerland
-
-
Credit Suisse was able to rack up more than $8bn of demand for its additional tier one deal on Wednesday in the face of jittery equity markets, as Rabobank had done the day before. -
Swiss healthcare company Roche took advantage of upcoming redemptions and a new investor base following its rating upgrade by Moody’s, to raise CHF900m ($922m) from a dual tranche offering.
-
SIG Combibloc, the Swiss food and beverage packaging company, is to relist on the Swiss stock exchange after more than a decade of being a private company.
-
SIX, an exchange company in Switzerland, is angling to take full advantage of the advent of distributed ledger technology (DLT). With its new digital asset platform, the company hopes to profit from easier securities settlement and a new method of raising capital that involves issuing cryptocurrency.
-
Tobias Rihs, the son of the late Swiss billionaire Andreas Rihs, has sold Sfr314.9m of shares in Sonova Holding, the Swiss maker of hearing aids, from the estate of his father.
-
The secondary performance of Credit Suisse’s additional tier one (AT1) bond issued on Monday led market participants to talk about the asset class finding its feet again after a torrid time recently.
-
Financial Conduct Authority chief Andrew Bailey on Thursday set out the options for forward-looking term rates to replace Libor, a family of benchmarks that he described as “vulnerable to misconduct”.
-
Idorsia, the Swiss biopharmaceutical company, has raised Sfr505m ($503.82m) to finance advanced clinical trials after a simultaneous share and convertible bond sale overnight in Zurich.
-
Credit Suisse's latest additional tier one (AT1) was well above par in the secondary market on Tuesday, as some investors thought the large size of the deal would boost its trading level.
-
Credit Suisse was looking to complete to raise additional tier one (AT1) capital on Monday and to become only the second bank to launch a benchmark-sized transaction in the format since April.
-
Swiss engineering firm Oerlikon has postponed the Zurich listing of its drive solutions business, GrazianoFairfield, citing volatile markets. But investors looking at the deal said the price was wrong and pointed to the trading performance of a similar deal when explaining the stalled IPO.
